BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 22314183)

  • 1. Colorectal poorly differentiated neuroendocrine carcinomas and mixed adenoneuroendocrine carcinomas: insights into the diagnostic immunophenotype, assessment of methylation profile, and search for prognostic markers.
    La Rosa S; Marando A; Furlan D; Sahnane N; Capella C
    Am J Surg Pathol; 2012 Apr; 36(4):601-11. PubMed ID: 22314183
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Up-regulation of the hypoxia-inducible factor-1 transcriptional pathway in colorectal carcinomas.
    Furlan D; Sahnane N; Carnevali I; Cerutti R; Bertoni F; Kwee I; Uccella S; Bertolini V; Chiaravalli AM; Capella C
    Hum Pathol; 2008 Oct; 39(10):1483-94. PubMed ID: 18619649
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Microsatellite unstable gastrointestinal neuroendocrine carcinomas: a new clinicopathologic entity.
    Sahnane N; Furlan D; Monti M; Romualdi C; Vanoli A; Vicari E; Solcia E; Capella C; Sessa F; La Rosa S
    Endocr Relat Cancer; 2015 Feb; 22(1):35-45. PubMed ID: 25465415
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Colorectal poorly differentiated neuroendocrine carcinomas frequently exhibit BRAF mutations and are associated with poor overall survival.
    Olevian DC; Nikiforova MN; Chiosea S; Sun W; Bahary N; Kuan SF; Pai RK
    Hum Pathol; 2016 Mar; 49():124-34. PubMed ID: 26826419
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Is nonsmall cell type high-grade neuroendocrine carcinoma of the tubular gastrointestinal tract a distinct disease entity?
    Shia J; Tang LH; Weiser MR; Brenner B; Adsay NV; Stelow EB; Saltz LB; Qin J; Landmann R; Leonard GD; Dhall D; Temple L; Guillem JG; Paty PB; Kelsen D; Wong WD; Klimstra DS
    Am J Surg Pathol; 2008 May; 32(5):719-31. PubMed ID: 18360283
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An immunohistochemical study of cervical neuroendocrine carcinomas: Neoplasms that are commonly TTF1 positive and which may express CK20 and P63.
    McCluggage WG; Kennedy K; Busam KJ
    Am J Surg Pathol; 2010 Apr; 34(4):525-32. PubMed ID: 20182342
    [TBL] [Abstract][Full Text] [Related]  

  • 7. RUNX3 promoter methylation in colorectal cancer: its relationship with microsatellite instability and its suitability as a novel serum tumor marker.
    Nishio M; Sakakura C; Nagata T; Komiyama S; Miyashita A; Hamada T; Kuryu Y; Ikoma H; Kubota T; Kimura A; Nakanishi M; Ichikawa D; Fujiwara H; Okamoto K; Ochiai T; Kokuba Y; Sonoyama T; Ida H; Ito K; Chiba T; Ito Y; Otsuji E
    Anticancer Res; 2010 Jul; 30(7):2673-82. PubMed ID: 20682997
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinicopathologic study of 62 acinar cell carcinomas of the pancreas: insights into the morphology and immunophenotype and search for prognostic markers.
    La Rosa S; Adsay V; Albarello L; Asioli S; Casnedi S; Franzi F; Marando A; Notohara K; Sessa F; Vanoli A; Zhang L; Capella C
    Am J Surg Pathol; 2012 Dec; 36(12):1782-95. PubMed ID: 23026929
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Achaete-scute homolog 1 as a marker of poorly differentiated neuroendocrine carcinomas of different sites: a validation study using immunohistochemistry and quantitative real-time polymerase chain reaction on 335 cases.
    La Rosa S; Marando A; Gatti G; Rapa I; Volante M; Papotti M; Sessa F; Capella C
    Hum Pathol; 2013 Jul; 44(7):1391-9. PubMed ID: 23375646
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aberrant pattern of the cytokeratin 7/cytokeratin 20 immunophenotype in colorectal adenocarcinomas with BRAF mutations.
    Gurzu S; Jung I
    Pathol Res Pract; 2012 Mar; 208(3):163-6. PubMed ID: 22361037
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Colorectal mixed adenoneuroendocrine carcinomas and neuroendocrine carcinomas are genetically closely related to colorectal adenocarcinomas.
    Jesinghaus M; Konukiewitz B; Keller G; Kloor M; Steiger K; Reiche M; Penzel R; Endris V; Arsenic R; Hermann G; Stenzinger A; Weichert W; Pfarr N; Klöppel G
    Mod Pathol; 2017 Apr; 30(4):610-619. PubMed ID: 28059096
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gastric neuroendocrine carcinoma: clinicopathologic review and immunohistochemical study of E-cadherin and Ki-67 as prognostic markers.
    Boo YJ; Park SS; Kim JH; Mok YJ; Kim SJ; Kim CS
    J Surg Oncol; 2007 Feb; 95(2):110-7. PubMed ID: 17066436
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comprehensive analysis of mutational and clinicopathologic characteristics of poorly differentiated colorectal neuroendocrine carcinomas.
    Lee SM; Sung CO
    Sci Rep; 2021 Mar; 11(1):6203. PubMed ID: 33737597
    [TBL] [Abstract][Full Text] [Related]  

  • 14. RHAMM, p21 combined phenotype identifies microsatellite instability-high colorectal cancers with a highly adverse prognosis.
    Zlobec I; Baker K; Terracciano LM; Lugli A
    Clin Cancer Res; 2008 Jun; 14(12):3798-806. PubMed ID: 18559599
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinicopathologic features of neuroendocrine carcinomas of the stomach: appraisal of small cell and large cell variants.
    Matsui K; Jin XM; Kitagawa M; Miwa A
    Arch Pathol Lab Med; 1998 Nov; 122(11):1010-7. PubMed ID: 9822131
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aberrant expression of human achaete-scute homologue gene 1 in the gastrointestinal neuroendocrine carcinomas.
    Shida T; Furuya M; Nikaido T; Kishimoto T; Koda K; Oda K; Nakatani Y; Miyazaki M; Ishikura H
    Clin Cancer Res; 2005 Jan; 11(2 Pt 1):450-8. PubMed ID: 15701827
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Microsatellite instability and survival rate in the solid or nonsolid types of poorly differentiated colorectal adenocarcinoma.
    Goi T; Hirono Y; Katayama K; Yamaguchi A
    Int Surg; 2004; 89(2):100-6. PubMed ID: 15285243
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High CpG island methylator phenotype is associated with lymph node metastasis and prognosis in gastric cancer.
    Chen HY; Zhu BH; Zhang CH; Yang DJ; Peng JJ; Chen JH; Liu FK; He YL
    Cancer Sci; 2012 Jan; 103(1):73-9. PubMed ID: 22017425
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metallothionein expression in colorectal cancer: relevance of different isoforms for tumor progression and patient survival.
    Arriaga JM; Levy EM; Bravo AI; Bayo SM; Amat M; Aris M; Hannois A; Bruno L; Roberti MP; Loria FS; Pairola A; Huertas E; Mordoh J; Bianchini M
    Hum Pathol; 2012 Feb; 43(2):197-208. PubMed ID: 21820154
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential expression of the AP-1 transcription factor family members in human colorectal epithelial and neuroendocrine neoplasms.
    Zhang W; Hart J; McLeod HL; Wang HL
    Am J Clin Pathol; 2005 Jul; 124(1):11-9. PubMed ID: 15923159
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.